Transfer-molded wrappable microneedle meshes for perivascular drug delivery

Ji Yong Lee, Dae Hyun Kim, Kang Ju Lee, Il Ho Seo, Seung Hyun Park, Eui Hwa Jang, Youngjoo Park, Young Nam Youn, Won Hyoung Ryu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

After surgical procedures such as coronary/peripheral bypass grafting or endarterectomy for the treatment of organ ischemia derived from atherosclerosis, intimal hyperplasia (IH) which leads to restenosis or occlusion at the site of graft anastomosis frequently occurs. In order to inhibit IH caused by abnormal growth of smooth muscle cells (SMCs) in tunica media, various perivascular drug delivery devices are reported for delivery of anti-proliferation drugs into vascular tissue. However, there still remain conflicting requirements such as local and unidirectional delivery vs device porosity, and conformal tight device installation vs pulsatile expansion and constriction of blood vessels. In this study, a biodegradable microneedle (MN) array is developed on a flexible woven surgical mesh using a transfer molding method. Mechanical properties of ‘wrappable’ MN meshes are investigated and compared to the properties of blood vessels. Ex vivo and in vivo animal studies demonstrate enhanced drug delivery efficiency, efficacy for IH reduction, and safety of MN mesh. In particular, MN mesh showed significantly reduced neointiamal formation (11.1%) compared to other competitive groups (23.7 and 22.2%) after 4-week in vivo animal study. Additionally, wrappable MN meshes effectively suppressed side effects such as IH due to mechanical constriction, loss of toxic drug to the surroundings, and cell death that were frequently observed with other previous perivascular drug delivery devices.

Original languageEnglish
Pages (from-to)237-246
Number of pages10
JournalJournal of Controlled Release
Volume268
DOIs
Publication statusPublished - 2017 Dec 28

Fingerprint

Tunica Intima
Hyperplasia
Blood Vessels
Equipment and Supplies
Pharmaceutical Preparations
Constriction
Surgical Mesh
Tunica Media
Endarterectomy
Poisons
Porosity
Smooth Muscle Myocytes
Atherosclerosis
Cell Death
Ischemia
Transplants
Safety
Growth

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Lee, Ji Yong ; Kim, Dae Hyun ; Lee, Kang Ju ; Seo, Il Ho ; Park, Seung Hyun ; Jang, Eui Hwa ; Park, Youngjoo ; Youn, Young Nam ; Ryu, Won Hyoung. / Transfer-molded wrappable microneedle meshes for perivascular drug delivery. In: Journal of Controlled Release. 2017 ; Vol. 268. pp. 237-246.
@article{271946b5777943b0bc4ef04b1858a33a,
title = "Transfer-molded wrappable microneedle meshes for perivascular drug delivery",
abstract = "After surgical procedures such as coronary/peripheral bypass grafting or endarterectomy for the treatment of organ ischemia derived from atherosclerosis, intimal hyperplasia (IH) which leads to restenosis or occlusion at the site of graft anastomosis frequently occurs. In order to inhibit IH caused by abnormal growth of smooth muscle cells (SMCs) in tunica media, various perivascular drug delivery devices are reported for delivery of anti-proliferation drugs into vascular tissue. However, there still remain conflicting requirements such as local and unidirectional delivery vs device porosity, and conformal tight device installation vs pulsatile expansion and constriction of blood vessels. In this study, a biodegradable microneedle (MN) array is developed on a flexible woven surgical mesh using a transfer molding method. Mechanical properties of ‘wrappable’ MN meshes are investigated and compared to the properties of blood vessels. Ex vivo and in vivo animal studies demonstrate enhanced drug delivery efficiency, efficacy for IH reduction, and safety of MN mesh. In particular, MN mesh showed significantly reduced neointiamal formation (11.1{\%}) compared to other competitive groups (23.7 and 22.2{\%}) after 4-week in vivo animal study. Additionally, wrappable MN meshes effectively suppressed side effects such as IH due to mechanical constriction, loss of toxic drug to the surroundings, and cell death that were frequently observed with other previous perivascular drug delivery devices.",
author = "Lee, {Ji Yong} and Kim, {Dae Hyun} and Lee, {Kang Ju} and Seo, {Il Ho} and Park, {Seung Hyun} and Jang, {Eui Hwa} and Youngjoo Park and Youn, {Young Nam} and Ryu, {Won Hyoung}",
year = "2017",
month = "12",
day = "28",
doi = "10.1016/j.jconrel.2017.10.007",
language = "English",
volume = "268",
pages = "237--246",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

Lee, JY, Kim, DH, Lee, KJ, Seo, IH, Park, SH, Jang, EH, Park, Y, Youn, YN & Ryu, WH 2017, 'Transfer-molded wrappable microneedle meshes for perivascular drug delivery', Journal of Controlled Release, vol. 268, pp. 237-246. https://doi.org/10.1016/j.jconrel.2017.10.007

Transfer-molded wrappable microneedle meshes for perivascular drug delivery. / Lee, Ji Yong; Kim, Dae Hyun; Lee, Kang Ju; Seo, Il Ho; Park, Seung Hyun; Jang, Eui Hwa; Park, Youngjoo; Youn, Young Nam; Ryu, Won Hyoung.

In: Journal of Controlled Release, Vol. 268, 28.12.2017, p. 237-246.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transfer-molded wrappable microneedle meshes for perivascular drug delivery

AU - Lee, Ji Yong

AU - Kim, Dae Hyun

AU - Lee, Kang Ju

AU - Seo, Il Ho

AU - Park, Seung Hyun

AU - Jang, Eui Hwa

AU - Park, Youngjoo

AU - Youn, Young Nam

AU - Ryu, Won Hyoung

PY - 2017/12/28

Y1 - 2017/12/28

N2 - After surgical procedures such as coronary/peripheral bypass grafting or endarterectomy for the treatment of organ ischemia derived from atherosclerosis, intimal hyperplasia (IH) which leads to restenosis or occlusion at the site of graft anastomosis frequently occurs. In order to inhibit IH caused by abnormal growth of smooth muscle cells (SMCs) in tunica media, various perivascular drug delivery devices are reported for delivery of anti-proliferation drugs into vascular tissue. However, there still remain conflicting requirements such as local and unidirectional delivery vs device porosity, and conformal tight device installation vs pulsatile expansion and constriction of blood vessels. In this study, a biodegradable microneedle (MN) array is developed on a flexible woven surgical mesh using a transfer molding method. Mechanical properties of ‘wrappable’ MN meshes are investigated and compared to the properties of blood vessels. Ex vivo and in vivo animal studies demonstrate enhanced drug delivery efficiency, efficacy for IH reduction, and safety of MN mesh. In particular, MN mesh showed significantly reduced neointiamal formation (11.1%) compared to other competitive groups (23.7 and 22.2%) after 4-week in vivo animal study. Additionally, wrappable MN meshes effectively suppressed side effects such as IH due to mechanical constriction, loss of toxic drug to the surroundings, and cell death that were frequently observed with other previous perivascular drug delivery devices.

AB - After surgical procedures such as coronary/peripheral bypass grafting or endarterectomy for the treatment of organ ischemia derived from atherosclerosis, intimal hyperplasia (IH) which leads to restenosis or occlusion at the site of graft anastomosis frequently occurs. In order to inhibit IH caused by abnormal growth of smooth muscle cells (SMCs) in tunica media, various perivascular drug delivery devices are reported for delivery of anti-proliferation drugs into vascular tissue. However, there still remain conflicting requirements such as local and unidirectional delivery vs device porosity, and conformal tight device installation vs pulsatile expansion and constriction of blood vessels. In this study, a biodegradable microneedle (MN) array is developed on a flexible woven surgical mesh using a transfer molding method. Mechanical properties of ‘wrappable’ MN meshes are investigated and compared to the properties of blood vessels. Ex vivo and in vivo animal studies demonstrate enhanced drug delivery efficiency, efficacy for IH reduction, and safety of MN mesh. In particular, MN mesh showed significantly reduced neointiamal formation (11.1%) compared to other competitive groups (23.7 and 22.2%) after 4-week in vivo animal study. Additionally, wrappable MN meshes effectively suppressed side effects such as IH due to mechanical constriction, loss of toxic drug to the surroundings, and cell death that were frequently observed with other previous perivascular drug delivery devices.

UR - http://www.scopus.com/inward/record.url?scp=85032274622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032274622&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2017.10.007

DO - 10.1016/j.jconrel.2017.10.007

M3 - Article

C2 - 29030224

AN - SCOPUS:85032274622

VL - 268

SP - 237

EP - 246

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -